did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780195152746

Late-Life Depression

by ;
  • ISBN13:

    9780195152746

  • ISBN10:

    0195152743

  • Format: Hardcover
  • Copyright: 2004-07-15
  • Publisher: Oxford University Press

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

  • Free Shipping Icon Free Shipping On Orders Over $35!
    Your order must be $35 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • eCampus.com Logo Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $176.00 Save up to $65.12
  • Rent Book $110.88
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    USUALLY SHIPS IN 3-5 BUSINESS DAYS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

We live in an aging world. Illnesses that are prevalent and cause significant morbidity and mortality in older people will consume an increasing share of health care resources. One such illness is depression. This illness has a particularly devastating impact in the elderly because it is oftenundiagnosed or inadequately treated. Depression not only has a profound impact on quality of life but it is associated with an increased risk of mortality from suicide and vascular disease. In fact for every medical illness studied, e.g. heart disease, diabetes, cancer, individuals who are depressedhave a worse prognosis. Research has illuminated the physiological and behavioral effects of depression that accounts for these poor outcomes. The deleterious relationship between depression and other illnesses has changed the concept of late-life depression from a "psychiatric disorder" that isdiagnosed and treated by a psychiatrist to a common and serious disorder that is the responsibility of all physicians who care for patients over the age of 60. This is the first volume devoted to the epidemiology, phenomenology, psychobiology, treatment and consequences of late-life depression. Although much has been written about depressive disorders, the focus has been primarily on the illness as experienced in younger adults. The effects of aging onthe brain, the physiological and behavioral consequences of recurrent depression, and the impact of other diseases common in the elderly, make late-life depression a distinct entity. There is a compelling need for a separate research program, specialized treatments, and a book dedicated to thisdisorder. This book will be invaluable to psychiatrists, gerontologists, clinical psychologists, social workers, students, trainees, and others who care for individuals over the age of sixty.

Table of Contents

Contributors xvii
Introduction xxi
PART I EPIDEMIOLOGY AND THE BURDEN OF ILLNESS
The Epidemiology of Depressive Disorders in Late Life
3(9)
Dan G. Blazer
Case Identification
3(1)
Prevalence, Incidence, and Distribution
4(3)
Prognosis
7(1)
Historical Trends
8(1)
Use of Psychiatric Services
8(4)
The Social and Financial Burden of Late-Life Depression to Society and Individuals
12(9)
Barry D. Lebowitz
Jason T. Olin
Mortality
13(1)
Co-Morbidity and Disability
13(1)
Health-Care Service and Resource Use
13(1)
Suicide and Late-Life Depression
14(7)
PART II THE PHENOMENOLOGY AND DIFFERENTIAL DIAGNOSIS OF LATE-LIFE MOOD DISORDERS
Unipolar Depression
21(13)
George S. Alexopoulos
William Apfeldorf
Diagnosing Late-Life Depression
21(2)
Other Syndromes of Late-Life Depression
23(1)
Assessment
24(2)
Course and Consequences of Late-Life Depression
26(1)
Medical Co-Morbidity
27(1)
Cognitive Impairment Disorders
27(1)
Disability
28(1)
Suicide
29(1)
Barriers to Effective Recognition and Treatment of Geriatric Unipolar Depression
29(5)
Bipolar Disorders
34(15)
Robert C. Young
Historical Perspective
34(1)
Diagnosis
34(1)
Differential Diagnosis of Mania in Late Life
35(1)
Epidemiology
35(1)
Pathophysiology and Etiology
36(2)
Features of Episodes: Psychopathology and Its Assessment
38(1)
Cognitive Impairment
39(1)
Function/Behavioral Disability
40(1)
Course of Illness: Chronicity
40(1)
Course of Illness: Relapse and Recurrence
41(1)
Course of Illness: Suicide
41(1)
Course of Illness: Psychiatric Services Use and Caregiver Burden
41(1)
Modification of the Course by Other Age-Associated Factors
41(1)
Nonaffective Outcomes
42(1)
Response to Antimanic Treatment
43(1)
Response to Antidepressant Treatment in Bipolar Depression
44(1)
Relapse and Recurrence in Maintenance Treatment
44(5)
Dysthymic Disorder in the Elderly
49(15)
D.P. Devanand
Prevalence
49(1)
Diagnosis
50(1)
Age-at-Onset
51(1)
Co-Morbidity
52(1)
Family History
52(1)
Social Adjustment, Quality of Life, and Disability
53(1)
Prognosis
53(1)
Dysthymic Disorder in Primary Care
54(1)
Rating Scales
54(1)
Neurobiology
55(2)
Treatment
57(1)
Long-Term Response and Relapse
58(1)
Antipsychotic Medications
58(1)
Psychotherapy
58(6)
Nonmajor Clinically Significant Depression in the Elderly
64(17)
Anand Kumar
Helen Lavretsky
Virginia Elderkin-Thompson
Nosological and Diagnostic Complexities
64(1)
Historical Perspective
64(1)
Stability of Syndromes and Psychiatric Diagnoses
65(1)
Differential Diagnosis: Minor Depression
66(1)
Differential Diagnosis: Subsyndromal Depressive Spectrum
67(1)
Differential Diagnosis: Other Diagnostic Categories
67(1)
Does Geriatric Nonmajor Clinically Significant Depression Differ from Depression in Younger Adults?
67(1)
Epidemiology and Clinical Features
68(2)
Genetics
70(1)
Neuroimaging, and Neuropsychological and Polysomnographic Studies
70(5)
Treatment
75(6)
Mixed Cognitive and Depressive Syndromes
81(14)
Helen Lavretsky
Gary W. Small
Depression in Dementia
82(1)
Putative Common Neurobiological Mechanisms of Dementia and Depression
82(1)
Cerebrovascular Disease and Depression in Dementia
83(1)
Cognition in Late-Life Depression
84(1)
Is ``Pseudodementia'' Real?
84(1)
Neuropsychological Studies of Cognition in Late-Life Depression
85(1)
Cognitive Impairment Associated with Subclinical Cerebrovascular Disease in Late-Life Depression
86(1)
Other Markers of Cognitive Impairment and Decline in Geriatric Depression: Neuropsychological Measures
86(1)
Other Markers: Structural Neuroimaging
86(1)
Other Markers: Functional Neuroimaging
87(1)
Other Markers: Genetic Markers
87(1)
Other Markers: Stress Hormones and Other Peripheral Biochemical Markers
88(1)
Course and Outcome of Depression with Cognitive Impairment
88(1)
Effects of Antidepressant Treatment on Cognitive Functions
89(1)
Diagnosis and Differential Diagnosis
89(6)
Suicide
95(12)
Yeates Conwell
Methodological Issues
95(1)
Prevalence of Suicidal Behaviors in Late Life
95(2)
Neurobiology of Late-Life Suicide
97(1)
Mental Health
98(1)
Physical Health and Function
99(1)
Social Factors
100(1)
Access to Lethal Means
100(1)
Summary of Risk
101(1)
Approaches to Prevention
101(1)
Universal Prevention
101(1)
Selective Prevention
101(1)
Indicated Prevention
102(5)
Bereavement and Depression
107(10)
Paula J. Clayton
Stages
107(1)
Psychological and Somatic Depressive Symptoms and Course of Bereavement
107(2)
Physical Symptoms, Substance Use, and Medical Treatment
109(1)
Mortality
110(1)
Psychiatric Disorders---Depression, Anxiety, and Mania
111(1)
Complicated or Traumatic Bereavement
111(1)
Predictors of Pathological Outcomes
112(1)
Treatment
112(5)
PART III THE PSYCHOBIOLOGY OF LATE-LIFE DEPRESSION
Neuropsychological Assessment of Late-Life Depression
117(12)
Wilfred G. Van Gorp
James C. Root
Harold A. Sackeim
The Effect of Age on Neuropsychological Functioning: Age-Appropriate Cognitive Decline
117(2)
Profile of Depression-Associated Cognitive Decline
119(1)
Attention
119(1)
Verbal Processing
120(1)
Visuospatial Processing
120(1)
Memory
121(1)
Processing Speed
122(1)
Executive Functioning
122(1)
The Interaction of Age and Depression on Neuropsychological Functioning
123(1)
The Interaction of Age-at-Onset and Depressive Cognitive Decline
124(1)
Neuropsychological Assessment of Late-Life Depression
125(4)
Structural and Functional Brain Imaging in Late-Life Depression
129(19)
Harold A. Sackeim
Brain Structural Abnormalities: Magnetic Resonance Imaging Hyperintensities
129(2)
Clinical Correlates
131(2)
Etiology of Encephalomalacia
133(3)
Longitudinal Perspective
136(1)
Volumetric Brain Structural Abnormalities: Ventricular Enlargement and Sulcal Prominence
136(3)
Brain Structural Morphometry
139(1)
Functional Brain Abnormalities
139(2)
Treatment and Recovery Effects in Late-Life Depression
141(7)
Late-Life Depression and the Vascular Hypothesis
148(9)
K. Ranga R. Krishnan
Development of Concepts Relating Brain Structural Change and Depression
148(1)
Risk Factors for Hyperintensities
148(1)
Lesion Location and Geriatric Depression
149(1)
Depression Outcomes of Patients with Vascular Brain Changes
150(1)
Lesions and Electroconvulsive Therapy Outcome
150(1)
Executive Dysfunction and Vascular Depression
151(1)
Cognitive Outcomes of Geriatric Depression
151(1)
Cognitive Outcomes of Vascular Depression
151(1)
Apolipoprotein E and Cognition
151(1)
Morbidity and Mortality Outcomes of Vascular Depression
152(1)
Leukoaraiosis and Lacunar Stroke: Apparently Different Outcomes
152(1)
Conceptual Framework
152(1)
Hippocampus and Geriatric Depression
153(4)
Hypothalamic-Pituitary-Adrenal Axis Activity in Mood and Cognition in the Elderly: Implications for Symptoms and Outcomes
157(10)
Jennifer Keller
Theresa M. Buckley
Alan F. Schatzberg
Regulation and Function of the Hypothalamic-Pituitary-Adrenal Axis
157(1)
Hypothalamic-Pituitary-Adrenal Axis and Depression
158(1)
Geriatric Depression, Cognition, and Hypothalamic-Pituitary-Adrenal Activity
159(1)
Aging and Hypothalamic-Pituitary-Adrenal Activity
159(1)
Depression, Dementia, and Hypothalamic-Pituitary-Adrenal Activity
160(1)
Brain Structures in Cognition and Depression
160(1)
Frontal Lobe
161(1)
Limbic and Fronto-Striatal Connections
161(1)
Hippocampus and Amygdala
161(1)
Depression, Againg, and Mortality
162(5)
The Neuroendocrinology of Aging
167(18)
Stuart N. Seidman
Hormones and Neuropsychiatry
167(1)
Central Nervous System Mechanisms of Hormonal Action
167(1)
Age-Related Changes in Hormone Axes
168(1)
Carbohydrate Metabolism
168(1)
Parathyroid
168(1)
Hypothalamic-Pituitary-Thyroid Axis
168(1)
Hypothalamic-Pituitary-Adrenal Axis
169(1)
Dehydroepiandrosterone
169(1)
Growth Hormone
170(1)
Prolactin
170(1)
Female Hypothalamic-Pituitary-Gonadal Axis
171(1)
Male Hypothalamic-Pituitary-Gonadal Axis
171(1)
Depression and Neuroendocrine Dysregulation in the Elderly
172(1)
Hormonal Axis Dysregulation and Late-Life Depression
173(1)
Hypothalamic-Pituitary-Adrenal Axis, Depression, and Age
173(1)
Dehydroepiandrosterone, Depression, and Age
174(1)
Hypothalamic-Pituitary-Thyroid Axis, Depression, and Age
175(1)
Hypothalamic-Pituitary-Gonadal Axis, Depression, and Age
175(1)
Testosterone and Male Neuropsychiatric Functioning
175(2)
Male Depressive Illness, Hypothalamic-Pituitary-Gonadal Axis Functioning, and Age
177(8)
PART IV TREATMENT
Pharmacokinetics and Pharmacodynamics in Late Life
185(7)
Bruce G. Pollock
Age-Associated Physiological Changes
186(1)
Pharmacokinetics
187(2)
Pharmacodynamics
189(3)
Antidepressant Medication for the Treatment of Late-Life Depression
192(11)
Steven P. Roose
Harold A. Sackeim
Moderators and Mediators of the Antidepressant Response
192(3)
Antidepressant Medications
195(1)
Tricyclic Antidepressants
195(1)
Selective Serotonin Reuptake Inhibitors
196(1)
Fluoxetine
196(1)
Sertraline
196(1)
Paroxetine
197(1)
Citalopram
197(1)
Selective Serotonin Reuptake Inhibitor Side Effect Profile in Geriatric Patients
197(1)
Other Antidepressants
197(1)
Placebo versus Comparator Controlled Trials
198(5)
Antidepressant Side Effects
203(8)
Carl Salzman
The Increased Likelihood of an Elderly Person Developing Side Effects
203(1)
Receptor Mechanisms of Antidepressant Side Effects in the Elderly
204(2)
Cardiovascular Side Effects
206(1)
Vascular Side Effects
207(1)
Falls
207(1)
Inappropriate Antidiuretic Hormone Secretion
207(1)
Weight Alterations
208(1)
Medication Noncompliance as a Risk for Antidepressant Adverse Events
208(3)
Mood Stabilizers
211(11)
Charles L. Bowden
The Prevention of Depression in Elderly Bipolar Patients
212(1)
Difficulties in Conducting Studies of Mood Stabilizers in Elderly Patients
212(1)
Evidence of Spectrum of Efficacy, Tolerability, and Dosing
213(1)
Effects of Other Disorders on Lithium Efficacy and Tolerability
214(1)
Effects of Lithium on Organ Systems
214(1)
Valproate Use in Elderly Patients
215(7)
Stimulants
222(10)
J. Craig Nelson
History
222(1)
Pharmacology
222(1)
Mechanism of Action
222(2)
Evidence for the Efficacy of Stimulants in Depression
224(2)
Stimulants for Augmentation
226(1)
Dextroamphetamine versus Methylphenidate
227(1)
Development of Tolerance during Depression Treatment
227(1)
Abuse Potential
227(1)
Side Effects
228(4)
Antipsychotics
232(9)
Christian R. Dolder
Jonathan P. Lacro
Dilip V. Jeste
Principles of Antipsychotic Use
232(1)
Antipsychotics in Depressive Disorders
233(2)
Antipsychotic Treatment Issues in the Elderly
235(6)
Electroconvulsive Therapy in Late-Life Depression
241(38)
Harold A. Sackeim
Use and Indications
241(2)
When to Consider Electroconvulsive Therapy
243(1)
Efficacy
244(10)
Medical Complications and Relative Contraindications
254(3)
Cognitive Side Effects
257(22)
Pharmacological Treatment of Depression in Alzheimer's Disease
279(8)
John L. Beyer
P. Murali Doraiswamy
Tricyclic Antidepressants
279(4)
Selective Serotonin Reuptake Inhibitors
283(1)
Monoamine Oxidase Inhibitors
284(1)
Newer Antidepressant Agents
284(1)
Electroconvulsive Therapy
285(1)
Guidelines for Treatment
285(2)
Psychotherapy in Old-Age Depression: Progress and Challenges
287(12)
Charles F. Reynolds III
Patricia A. Arean
Thomas R. Lynch
Ellen Frank
Rationale for Psychosocial Interventions and for Psychotherapy in the Treatment of Depression in Later Life
287(1)
Cognitive-Behavioral Therapy
288(2)
Interpersonal Psychotherapy
290(2)
Dialectical Behavior Therapy
292(2)
Psychotherapeutic Management of Suicidal Older Adult Patients
294(1)
Other Psychosocial Interventions
295(4)
Treatment of Depression in Residential Settings
299(12)
Ira R. Katz
Joel Streim
The Context: Nursing Homes in America
299(1)
The Regulatory Environment
300(1)
Clinical Psychiatry in the Nursing Home
300(4)
Evolution in the Epidemiology of Depression and Its Treatment
304(1)
Delivery of Clinical Care
305(6)
PART V DEPRESSION CO-MORBID WITH OTHER ILLNESSES
Depression Co-Morbid with Ischemic Heart Disease
311(10)
Steven P. Roose
Alexander H. Glassman
Depression in Patients with Cardiac Disease
311(1)
Depression and Development of Coronary Artery Disease
312(1)
The Effect of Depression on Cardiac Outcomes in Patients with Ischemic Heart Disease
312(1)
Physiological Mechanisms Underlying the Relationship Between Vascular Disease and Depression
313(1)
Depression and Sudden Cardiovascular Death
314(1)
Treatment of Depression in Patients with Ischemic Heart Disease
315(1)
The Cardiovascular Effects of Tricyclic Antidepressants
315(1)
The Antiarrhythmic Effect of Tricyclic Antidepressants: Cardiac Risk Reconsidered
315(1)
Tricyclic Antidepressants, Heart Rate Variability, and Cardiac Death
316(1)
The Cardiovascular Effects of the Selective Serotonin Reuptake Inhibitors
316(2)
Other Antidepressants
318(1)
Psychotherapy
318(3)
Vascular Disease and Late-Life Depression: Stroke
321(16)
Robert G. Robinson
Historical Perspective
321(1)
Diagnosis of Poststroke Depression
322(2)
Prevalence of Depression
324(1)
Duration of Depression
324(1)
Relationship to Lesion Variables
324(3)
Premorbid Risk Factors
327(1)
Poststroke Depression and Activities of Daily Living
327(2)
Poststroke Depression and Cognitive Impairment
329(2)
Poststroke Depression and Mortality
331(1)
Mechanism of Poststroke Depression
331(1)
Treatment of Poststroke Depression
332(5)
Substance Abuse Co-Morbidity
337(11)
David W. Oslin
Defining Co-Morbidity
337(1)
The Epidemiology of Late-Life Addictions
337(1)
The Co-Occurrence of Late-Life Depression and Use of Addictive Substances
338(3)
Diagnostic Considerations
341(1)
Treatment Issues
342(6)
Basal Ganglia Disease and Depression
348(13)
Anjan Chatterjee
Karen Marder
Introduction to Basal Ganglia Disease
348(1)
Anatomy and Connections of the Basal Ganglia
348(1)
The Neuroanatomy of Depression
349(1)
Parkinson's Disease
349(4)
Huntington's Disease
353(2)
Wilson's Disease
355(1)
Parkinson-Plus Syndromes and the Tauopathies
356(5)
Major Depressive Disorder in Alzheimer's Disease
361(9)
George S. Zubenko
Neuropathological and Neurochemical Correlates of Major Depressive Disorder in Alzheimer's Disease
361(3)
Mechanism(s) of Neuronal Death in Alzheimer's Disease
364(1)
Discussion
365(5)
Epilogue 370(5)
Index 375

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program